Insurance Coverage & Costs
Access to Care
Uninsured and Low-Income
Racial/Ethnic Disparities
Safety Net Providers
Community Health Centers
Hospitals
Physicians
Insured People
Quality & Care Delivery
Health Care Markets
Issue Briefs
Data Bulletins
Research Briefs
Policy Analyses
Community Reports
Journal Articles
Other Publications
Surveys
Site Visits
Design and Methods
Data Files
Table 7
Summary of Effects of State Medicaid Cost-Control Methods on Beneficiaries’ Access to Prescription Drugs1
| Percent not getting prescription drug due to cost2 | |
|---|---|
| State Has Implemented 0 or 1 Method | 15 |
| State Has Implemented 2 or 3 Methods | 25** |
| State Has Implemented 4 or 5 Methods | 33* |
1 These methods include copayments, limits on the number of prescriptions, mandatory substitution of generics for brand-name drugs, preauthorization requirements, and step-therapy requirements.
2 Estimates reflected regression-adjusted means, computed based on the coefficients from the regression model (see Appendix Table 3) and variable means for the sample of persons age 18-64 enrolled in Medicaid or other state coverage.
* Difference with persons in states that implemented 0 or 1 requirement is statistically significant at .05 level.
** Difference with persons in states that implemented 0 or 1 requirement is statistically significant at .10 level.
Note: Sample includes persons ages 18-64 enrolled in Medicaid or state coverage programs.
Source: Community Tracking Study Household Survey, 2000-01
